1. , , , , Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke 2005;36:1053–1058.
2. , , , et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 2010;120:433–445.
3. , , , In vivo measurement of cerebral blood flow: a review of methods and applications. Vasc Med 2001;6:51–60.
4. Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry 2004;75:353–361.
5. , MR perfusion imaging of the brain techniques and applications. AJR Am J Roentgenol 2000;175:207–219.
6. , Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of cerebral arteries. Invest Radiol 1967;2:17–32.
7. , , , et al. The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man. J Neurol Sci 2000;178:23–28.
8. , , Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990;2:161–192.
9. , , , Comparison of static and dynamic cerebral autoregulation measurements. Stroke 1995;26:1014–1019.
10. , , , Grading of cerebral dynamic autoregulation from spontaneous fluctuations in arterial blood pressure. Stroke 1998;29:2341–2346.
11. , , Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci (Lond) 2000;99:555–560.
12. , , , et al. The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study. J Cereb Blood Flow Metab 1999;19:673–678.
13. , , , Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke 1998;29:467–472.
14. , , , et al. [A comparison of MRT and SPECT findings in patients with cerebral microangiopathy.] Nuklearmedizin 1991;30:161–169 [in German].
15. , , , et al. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999;30:556–566.
16. , , , , Regional cerebral blood flow in lacunar infarction. J Stroke Cerebrovasc Dis 1997;6:137–140.
17. , , Cerebral blood flow in single and multiple lacunar infarctions. Stroke 1997;28:1458–1460.
18. , , , et al. Preserved acetazolamide reactivity in lacunar patients with severe white-matter lesions: 15O-labeled gas and H2O positron emission tomography studies. J Cereb Blood Flow Metab 2012;32:844–850.
19. , , , , Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry 2000;69:48–53.
20. , , , et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59:321–326.
21. , , , Leukoaraiosis correlates with cerebral hypoperfusion in vascular dementia. Stroke 1991;22:609–614.
22. , , , et al. Correlations of leukoaraiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. J Neurol Neurosurg Psychiatry 1993;56:182–187.
23. , , , , Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 1990;21:1694–1699.
24. , , , et al. Positron emission tomography in vascular dementia. J Neurol Sci 1998;21:55–61.
25. , , Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors. Stroke 1991;22:1379–1383.
26. , , . Cerebral small vessel disease in aging and Alzheimer’s disease: a comparative study using MRI and SPECT. Eur J Neurol 2013;20:243–250.
27. , , , et al. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1997;63:66–73.
28. , , , et al. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008;29:1296–1301.
29. , , Leukoaraiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch Neurol 1990;47:161–165.
30. , , , et al. Leukoaraiosis and cerebral perfusion in normal aging. Exp Aging Res 1993;19:225–240.
31. , , , Xenon contrast CT–CBF measurements in high-intensity foci on T2-weighted MR images in centrum semiovale of asymptomatic individuals. Stroke 1997;28:984–987.
32. , , , Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994;25:375–381.
33. , , , et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 2009;172:117–120.
34. , , , The impact of magnetic resonance imaging-detected white matter hyperintensities on longitudinal changes in regional cerebral blood flow. J Cereb Blood Flow Metab 2008;28:190–197.
35. , , , et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002;33:972–976.
36. , , , Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI. Neuroimage 2004;21:1350–1356.
37. , , , et al. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities. Radiology 2007;243:198–203.
38. , , , et al. Low cerebral blood flow velocity and risk of white matter hyperintensities. Ann Neurol 2001;49:411–414.
39. , , , , Brain atrophy and cerebral small vessel disease: a prospective follow-up study. Stroke 2011;42:133–138.
40. , , , et al. Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001;57:2307–2310.
41. , , , et al. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: a case-control study. Stroke 1999;30:2296–2301.
42. , , , Reduced vasomotor reactivity in cerebral microangiopathy: a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke 2000;31:924–929.
43. , , , et al. Reactivity of cerebral blood flow to carbon dioxide in various types of ischemic cerebrovascular disease: evaluation by the transcranial Doppler method. Stroke 1993;24:670–675.
44. , , , et al. Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study. Eur Neurol 1999;41:31–36.
45. , , , et al. Cerebral blood flow and vascular response to hypercapnia in hypertensive patients with leukoaraiosis. Ann Nucl Med 1996;10:293–298.
46. , , , et al. Reduced perfusion reserve in leukoaraiosis demonstrated using acetazolamide challenge 123I-IMP SPECT. J Comput Assist Tomogr 2007;31:884–887.
47. , , , et al. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 1994;23:565–568.
48. , , , et al. Dynamic cerebral autoregulation in acute lacunar and middle cerebral artery territory ischemic stroke. Stroke 2005;36:2595–2600.
49. , , , et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000;31:1904–1912.
50. , , , et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance. AJNR Am J Neuroradiol 2001;22:1268–1274.
51. , , , et al. Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke 2004;35:1063–1067.
52. , , , et al. Reduced cerebrovascular CO2 reactivity in CADASIL: a transcranial Doppler sonography study. Stroke 2001;32:17–21.
53. , Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). J Neurol 2005;252:163–167.
54. , , , et al. Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab 2003;23:599–604.
55. , , , et al. Cerebrovascular reactivity is a main determinant of white matter hyperintensity progression in CADASIL. AJNR Am J Neuroradiol 2009;30:1244–1247.
56. , , , et al. Acetazolamide improves cerebral hemodynamics in CADASIL. J Neurol Sci 2010;292:77–80.
57. , , , , Effects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL. J Neurol Sci 2007;260:100–105.